Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year [Yahoo! Finance]
Supernus Pharmaceuticals, Inc. (SUPN)
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.supernus.com
Company Research
Source: Yahoo! Finance
VP of IP and CSO at Supernus Pharmaceuticals (NASDAQ:SUPN) , reported the direct sale of 107,250 shares of Common Stock over March 16–18, 2026, via open-market transactions, for a transaction value of approximately $5.4 million, according to the SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value $5.4 million Post-transaction common shares (direct) Post-transaction value (direct ownership) ~$840K Transaction value based on SEC Form 4 weighted average purchase price ($50.24); post-transaction value based on March 18, 2026 market close ($50.24). Key questions What was the structure and timing of this transaction? The filing covers open-market sales executed from March 16 through March 18, 2026, with underlying shares stemming from the exercise of options, immediately sold alongside other directly held shares. How does this impact Bhatt's ongoing exposure to Supernus Pharmaceuticals? While direct Common Stock ownership d
Show less
Read more
Impact Snapshot
Event Time:
SUPN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SUPN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SUPN alerts
High impacting Supernus Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SUPN
News
- Newron Announces Agreement With the European Investment Bank (EIB) to Extend the Near-Term Tranche Repayment Dates of Its 2018 Finance Contract [Yahoo! Finance]Yahoo! Finance
- 3 Reasons SUPN is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Supernus Pharmaceuticals, Inc. (SUPN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Supernus Pharmaceuticals (SUPN) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=SUPN&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> froMarketBeat
- Supernus Pharmaceuticals (SUPN) was given a new $65.00 price target by Craig Hallum.MarketBeat
SUPN
Earnings
- 2/24/26 - Miss
SUPN
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/18/26 - Form 4
- 3/17/26 - Form 144
- SUPN's page on the SEC website